Stock Ticker

  • Loading stock data...

Can New Science Officer Rejuvenate InVivo Therapeutics? (NVIV)

InVivo Therapeutics (OTC: NVIV) announced an interim successor to fill the Chief Science Officer position recently vacated by Dr. Edward Wirth due to personal reasons. Brian Hess, a former product development specialist with Stryker (NYSE: SYK) and current product development manager for InVivo Therapeutics, will assume the role of Chief Science officer. Mr. Hess will take […]